Genflow Biosciences Shares Drop 6.3%

Biotech firm's stock falls amid market volatility

Mar. 21, 2026 at 1:08am

Got story updates? Submit your updates here. ›

Shares of Genflow Biosciences plc (LON:GENF), a UK-based biotech company focused on developing therapeutics to potentially halt or slow the aging process, fell 6.3% on Wednesday, trading as low as GBX 1.85 per share.

Why it matters

Genflow Biosciences is a relatively young biotech firm working on innovative anti-aging therapies, so its stock performance is closely watched by investors interested in the longevity science space. The 6.3% drop could signal broader market volatility impacting the company's valuation.

The details

The company's shares closed at GBX 1.85, down from the previous close of GBX 1.98. Trading volume was significantly lower than average, with just 14,538 shares changing hands compared to a typical daily volume of 2.7 million shares. Genflow has a 50-day moving average of GBX 1.94 and a 200-day moving average of GBX 1.79, and a market capitalization of £9.28 million.

  • Genflow Biosciences shares fell 6.3% on Wednesday, March 21, 2026.

The players

Genflow Biosciences plc

A UK-based biotech company with R&D facilities in Belgium and a US office in Cambridge, MA, focused on developing therapeutics to potentially halt or slow the aging process.

Got photos? Submit your photos here. ›

The takeaway

Genflow Biosciences' stock decline reflects the volatility in the biotech sector, but the company's focus on innovative longevity treatments continues to generate investor interest in its long-term potential.